← Evidence map

ArticleOncology letters2026

KRAS (G12D)-selective inhibitor MRTX1133 suppresses proliferation and differentially modulates chemosensitivity in ovarian mucinous carcinoma.

Ryota Watano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

KRAS (G12D)-selective inhibitor MRTX1133 suppresses proliferation and differentially modulates chemosensitivity in ovarian mucinous carcinoma. | OpenQuestion